Company Data

Cocrystal Pharma Inc.

Fundamental Analysis:

Cocrystal Pharma Inc.

Cocrystal Pharma Inc.
Fundamental Analysis:
Current Price
$2.89 2.48%
Market Cap
Price Target
Refer to Report
52wk Range
$1.74 - $7.5588
Advanced Market Data


Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.